Deretil

Spain Updated 9 July 2026

Deretil is an API manufacturer based in Spain. Its most recent recorded inspection, by US FDA, closed on 24 March 2023 as VAI.

active US DMFs

valid CEPs

registered plants 1 with an FDA FEI number

filings across 0 regulators

These figures were checked against the regulators' own files on 25 July 2026

Plants

1 of 1 confirmed

Inspections

5 of 5 confirmed

Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.

Inspection history

24 March 2023 VAI US FDA
13 March 2019 VAI US FDA
8 January 2016 NAI US FDA
26 September 2013 VAI US FDA
1 July 2010 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site	FDA FEI
Spain, Spain	3003747614

What they file, and where

Molecule	Regulators	Docs
Amoxicillin	SFDA (Saudi Arabia)	2

Also appears on these molecule pages

Amoxicillin API

Questions about Deretil

Is Deretil FDA-registered?

One site operated by Deretil carries an FDA establishment identifier (FEI), which means it is registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.

How did Deretil's last inspection go?

The most recent inspection on record closed on 24 March 2023 as VAI (Voluntary Action Indicated: issues were found but did not warrant regulatory action). 5 inspections are on file.

Where does Deretil manufacture?

1 registered site is on record, in Spain (Spain). Every site is listed on this page with the register it came from.

What does Deretil make?

1 molecule is on record against Deretil, including Amoxicillin. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Deretil comes back tiered against every other supplier able to file there.

Start for free

No sales call.

Open risk flags

The most recent inspection outcome was VAI, on 24 March 2023.

Comparable suppliers

Apitoria Pharma shares 1 molecule Acs Dobfar shares 1 molecule Sandoz shares 1 molecule Fresenius Kabi shares 1 molecule Teva shares 1 molecule

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA: Drug master files, establishment registration, inspection classifications
EDQM: Certificates of suitability